NCT02926573 · FLOW

Participant flow

Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients · Source last updated 2018-08-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

description
Gabapentin liquid by mouth or per Tube 300mg twice a day
id
FG000
title
Gabapentin
description
Placebo liquid by mouth or Per Tube twice a day
id
FG001
title
Placebo

periods

drop Withdraws
reasons
group Id
FG000
num Subjects
1
group Id
FG001
num Subjects
0
type
Nausea
reasons
group Id
FG000
num Subjects
2
group Id
FG001
num Subjects
2
type
Remain intubated
reasons
group Id
FG000
num Subjects
3
group Id
FG001
num Subjects
1
type
Change in surgery plan
reasons
group Id
FG000
num Subjects
5
group Id
FG001
num Subjects
1
type
Change to outpatient status
reasons
group Id
FG000
num Subjects
0
group Id
FG001
num Subjects
2
type
Withdrawal by Subject
reasons
group Id
FG000
num Subjects
0
group Id
FG001
num Subjects
2
type
Return to operating room
reasons
group Id
FG000
num Subjects
0
group Id
FG001
num Subjects
1
type
Delirium
milestones
achievements
group Id
FG000
num Subjects
55
group Id
FG001
num Subjects
55
type
STARTED
achievements
group Id
FG000
num Subjects
44
group Id
FG001
num Subjects
46
type
COMPLETED
achievements
group Id
FG000
num Subjects
11
group Id
FG001
num Subjects
9
type
NOT COMPLETED
title
Overall Study

pre Assignment Details

13 participants were enrolled but withdrew prior to study participation with no medication given. 8 participants withdrew due to patient preference and 5 withdrew due to cancellation of surgery.

recruitment Details

The study opened to participant enrollment on 06/24/2016 and closed to participant enrollment on 06/30/2017.

Complete source fields